Post-merger integration is key to M&A success, ensuring operational continuity, synergy realisation, and risk management.

The interaction with GSK goes deeper, with Novartis and GSK announcing a merger of their OTC divisions to create a new joint venture which will be number one in the sector. This mirrors an earlier ...

The merger of SmithKline Beecham Pharmaceuticals (India) Ltd into Glaxo India Limited was completed and the name of the company was changed to the present name GlaxoSmithKline Pharmaceuticals Ltd ...

GlaxoSmithKline was formerly called GlaxoWelcome before its merger with U.S. pharmaceutical company SmithKline Beecham in 2000. The combination has made GlaxoSmithKline the 6th largest ...

Lifescience Dynamics, a leading decision support firm that provides analysis and competitive intelligence for the top pharmaceutical companies, announces Navin Joshi has been appointed as the new VP ...

Key portfolio changes included exiting positions in MSC Industrial Direct and LyondellBasell, while adding GSK, US Bancorp ... New administration might mean fewer merger challenges, and the ...

The decision comes in the wake of changes to Novartis' organisational structure, including the merger of its pharmaceuticals ... healthcare joint venture with GlaxoSmithKline in 2018, and within ...

The proposed transaction is an all equity merger, under which on the Scheme becoming effective, 4.39 shares of the Company will be allotted for every share of GSK CH India.The acquisition is in ...

A former Wake Forest University faculty member, Fleming joined Glaxo Wellcome in late 1999, three months before the SmithKline Beecham merger. So he used the severance package he was offered and in ...

GSK, headquartered in Brentford, UK, is a global healthcare company with around 100,000 employees worldwide. It was formed from the merger of SmithKline Beecham and GlaxoWellcome in 2000. GSK delivers ...